Cargando…

WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC

BACKGROUND: Aberrant expression of Wiskott–Aldrich syndrome protein interacting protein family member 1 (WIPF1) contributes to the invasion and metastasis of several malignancies. However, the role of WIPF1 in human pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. METHODS: Human pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yu, Lu, Fengchun, Xiong, Ping, Pan, Maoen, Zhang, Zheyang, Lin, Xianchao, Pan, Minggui, Huang, Heguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056910/
https://www.ncbi.nlm.nih.gov/pubmed/30041660
http://dx.doi.org/10.1186/s13046-018-0848-6
_version_ 1783341414551126016
author Pan, Yu
Lu, Fengchun
Xiong, Ping
Pan, Maoen
Zhang, Zheyang
Lin, Xianchao
Pan, Minggui
Huang, Heguang
author_facet Pan, Yu
Lu, Fengchun
Xiong, Ping
Pan, Maoen
Zhang, Zheyang
Lin, Xianchao
Pan, Minggui
Huang, Heguang
author_sort Pan, Yu
collection PubMed
description BACKGROUND: Aberrant expression of Wiskott–Aldrich syndrome protein interacting protein family member 1 (WIPF1) contributes to the invasion and metastasis of several malignancies. However, the role of WIPF1 in human pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. METHODS: Human pancreatic cancer samples from PDAC patients were collected for methylation analysis. Bioinformatic prediction program and luciferase reporter assay were used to identify microRNAs regulating WIPF1 expression. The association between WIPF1 expression and the overall survival (OS) of patients with PDAC was evaluated by using The Cancer Genome Atlas (TCGA) database. The roles of miR-141/200c and WIPF1 on the invasion and metastasis of PDAC cells were investigated both in vitro and in vivo. RESULTS: We found that compared to the surrounding non-cancerous tissues, there was significantly increased methylation of miR-200c and miR-141 in human PDAC tissues that resulted in their silencing, whereas the members of the other cluster of miR-200 family including miR-200a, miR-200b and miR-429 were hypomethylated. Our data show that forced expression of miR-141 or miR-200c suppressed invasion and metastasis of PDAC cells both in vitro and in xenograft and identified WIPF1 as a direct target of miR-141 and miR-200c. Both miR-141 and miR-200c inhibit WIPF1 by directly interacting with its 3′-untranslated region. Remarkably, silencing of WIPF1 blocked PDAC growth and metastasis both in vitro and in vivo, whereas forced WIPF1 overexpression antagonized the tumor suppressive effect of miR-141/200c. Additionally, by using TCGA database we showed that high expression of WIPF1 correlated with poor survival in patients with PDAC. Moreover, we show that miR-141 and miR-200c blocked YAP/TAZ expression by suppressing WIPF1. CONCLUSIONS: We have identified WIPF1 as an oncoprotein in PDAC and a direct target of miR-141/miR-200c. We have also defined the miR-141/200c-WIPF1-YAP/TAZ as a novel signaling pathway that is involved in the regulation of the invasion and metastasis of human PDAC cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0848-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6056910
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60569102018-07-30 WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC Pan, Yu Lu, Fengchun Xiong, Ping Pan, Maoen Zhang, Zheyang Lin, Xianchao Pan, Minggui Huang, Heguang J Exp Clin Cancer Res Research BACKGROUND: Aberrant expression of Wiskott–Aldrich syndrome protein interacting protein family member 1 (WIPF1) contributes to the invasion and metastasis of several malignancies. However, the role of WIPF1 in human pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. METHODS: Human pancreatic cancer samples from PDAC patients were collected for methylation analysis. Bioinformatic prediction program and luciferase reporter assay were used to identify microRNAs regulating WIPF1 expression. The association between WIPF1 expression and the overall survival (OS) of patients with PDAC was evaluated by using The Cancer Genome Atlas (TCGA) database. The roles of miR-141/200c and WIPF1 on the invasion and metastasis of PDAC cells were investigated both in vitro and in vivo. RESULTS: We found that compared to the surrounding non-cancerous tissues, there was significantly increased methylation of miR-200c and miR-141 in human PDAC tissues that resulted in their silencing, whereas the members of the other cluster of miR-200 family including miR-200a, miR-200b and miR-429 were hypomethylated. Our data show that forced expression of miR-141 or miR-200c suppressed invasion and metastasis of PDAC cells both in vitro and in xenograft and identified WIPF1 as a direct target of miR-141 and miR-200c. Both miR-141 and miR-200c inhibit WIPF1 by directly interacting with its 3′-untranslated region. Remarkably, silencing of WIPF1 blocked PDAC growth and metastasis both in vitro and in vivo, whereas forced WIPF1 overexpression antagonized the tumor suppressive effect of miR-141/200c. Additionally, by using TCGA database we showed that high expression of WIPF1 correlated with poor survival in patients with PDAC. Moreover, we show that miR-141 and miR-200c blocked YAP/TAZ expression by suppressing WIPF1. CONCLUSIONS: We have identified WIPF1 as an oncoprotein in PDAC and a direct target of miR-141/miR-200c. We have also defined the miR-141/200c-WIPF1-YAP/TAZ as a novel signaling pathway that is involved in the regulation of the invasion and metastasis of human PDAC cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0848-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-24 /pmc/articles/PMC6056910/ /pubmed/30041660 http://dx.doi.org/10.1186/s13046-018-0848-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pan, Yu
Lu, Fengchun
Xiong, Ping
Pan, Maoen
Zhang, Zheyang
Lin, Xianchao
Pan, Minggui
Huang, Heguang
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title_full WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title_fullStr WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title_full_unstemmed WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title_short WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
title_sort wipf1 antagonizes the tumor suppressive effect of mir-141/200c and is associated with poor survival in patients with pdac
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056910/
https://www.ncbi.nlm.nih.gov/pubmed/30041660
http://dx.doi.org/10.1186/s13046-018-0848-6
work_keys_str_mv AT panyu wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT lufengchun wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT xiongping wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT panmaoen wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT zhangzheyang wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT linxianchao wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT panminggui wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac
AT huangheguang wipf1antagonizesthetumorsuppressiveeffectofmir141200candisassociatedwithpoorsurvivalinpatientswithpdac